Key Takeaways
- Longeny has launched truGut360™, a comprehensive gut microbiome test tailored for Indian consumers.
- The test analyzes various health markers, addressing issues like bloating, fatigue, and metabolic disorders.
- truGut360™ provides lab-grade insights from home, supporting proactive health management in a rising health-conscious population.
Innovative Gut Health Solution
Longeny, a health-tech startup focused on personalized preventive care, has unveiled truGut360™, an advanced gut microbiome test. This product, developed in collaboration with MyBioma from Austria, offers one of the most thorough microbiome analyses in India.
Many individuals suffering from chronic conditions such as bloating, fatigue, hormonal imbalances, and autoimmune disorders often lack clarity about their underlying health issues. truGut360™ aims to change this by examining factors like microbial diversity, inflammation levels, metabolic pathways, immune-gut interactions, digestion patterns, and early disease risk indicators.
The gut microbiome plays a critical role in overall health, with studies indicating that it influences up to 70% of the immune system and nearly 90% of metabolic activity. Research has linked gut dysbiosis—an imbalance in gut bacteria—to various chronic diseases, including obesity, diabetes, depression, and accelerated aging.
truGut360™ simplifies this complex science, transforming it into a user-friendly at-home test. Users can submit a sample and receive a detailed health report, allowing them to access insights once available only in elite research labs. This aligns with the growing trend of proactive health management, especially among younger populations in India, who are increasingly adopting health-conscious lifestyles.
As the demand for personalized healthcare solutions rises, truGut360™ marks a significant milestone in India’s healthcare transformation, helping individuals take charge of their health proactively.
The content above is a summary. For more details, see the source article.
